Prostate cancer chemopreventive efficacy and mechanisms of a novel sulindac derivative

被引：0
|
作者：
Zhang, Yong
Zhang, J.H.
Wang, Lei
Gary, Bernard
Reynolds, Robert
Piazza, Gary
Lu, Junxuan
Guha, Sushovan
机构：
来源：
CANCER RESEARCH | 2009年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
953
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Colon cancer chemopreventive properties of a non-cyclooxygenase inhibitory amide derivative of sulindac
    Piazza, Gary A.
    Keeton, Adam B.
    Tinsley, Heather N.
    Gary, Bernard D.
    Whitt, Jason D.
    Li, Nan
    Gurpinar, Evrim
    Sun, Yanjie
    Mathew, Bini
    Reynolds, Robert C.
    Zhang, Wei
    Singh, Raj
    Coward, Lori
    Gorman, Greg
    Maxuitenko, Yulia Y.
    Grizzle, William
    Chang, Wen-Chi
    Clapper, Margie
    CANCER RESEARCH, 2011, 71
  • [2] Chemopreventive efficacy of silymarin in skin and prostate cancer
    Deep, Gagan
    Agarwal, Rajesh
    INTEGRATIVE CANCER THERAPIES, 2007, 6 (02) : 130 - 145
  • [3] New molecular approaches for identifying novel targets, mechanisms, and biomarkers for prostate cancer chemopreventive agents
    Williams, ED
    Brooks, JD
    UROLOGY, 2001, 57 (4A) : 100 - 102
  • [4] Curcumin enhances the lung cancer chemopreventive efficacy of phospho-sulindac by improving its pharmacokinetics
    Cheng, Ka-Wing
    Wong, Chi C.
    Mattheolabakis, George
    Xie, Gang
    Huang, Liqun
    Rigas, Basil
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2013, 43 (03) : 895 - 902
  • [5] Chemopreventive efficacy and the underlying molecular mechanisms of anti-inflammatory agent licofelone against prostate cancer
    Narayanan, Narayanan
    Nargi, Dominick
    Rao, Chinthalapally
    Narayanan, Bhagavathi
    CANCER RESEARCH, 2009, 69
  • [6] Chemopreventive efficacy of sulindac sulfone against colon cancer depends on time of administration during carcinogenic process
    Reddy, BS
    Kawamori, T
    Lubet, RA
    Steele, VE
    Kelloff, GJ
    Rao, CV
    CANCER RESEARCH, 1999, 59 (14) : 3387 - 3391
  • [7] Breast cancer chemopreventive activity of a novel amide derivative of sulindac involves inhibition of PDE5, activation of PKG, and attenuation of Wnt/β-catenin signaling
    Tinsley, Heather N.
    Gary, Bernard D.
    Whitt, Jason
    Zhang, Wei
    Chen, Xi
    Keeton, Adam B.
    Grubbs, Clinton J.
    Grizzle, William E.
    Piazza, Gary A.
    CANCER RESEARCH, 2012, 72
  • [8] SSA, a novel sulindac derivative, inhibits breast cancer cell invasion and migration
    Yi, Bin
    Feng, Xingling
    Ma, Ruixia
    Zhang, Xiaoguo
    Chang, Hong
    Zhao, Hongyou
    Liang, Ziping
    Chen, Xi
    Hu, Xiuhua
    Piazza, Gary
    Xi, Yaguang
    CANCER RESEARCH, 2015, 75
  • [9] Phospho-Sulindac (OXT-328), a Novel Sulindac Derivative, Is Safe and Effective in Colon Cancer Prevention in Mice
    Mackenzie, Gerardo G.
    Sun, Yu
    Huang, Liqun
    Xie, Gang
    Ouyang, Nengtai
    Gupta, Ramesh C.
    Johnson, Francis
    Komninou, Despina
    Kopelovich, Levy
    Rigas, Basil
    GASTROENTEROLOGY, 2010, 139 (04) : 1320 - 1332
  • [10] Lovastatin augments sulindac-induced apoptosis in colon cancer cells and potentiates chemopreventive effects of sulindac
    Agarwal, B
    Rao, CV
    Bhendwal, S
    Ramey, WR
    Shirin, H
    Reddy, BS
    Holt, PR
    GASTROENTEROLOGY, 1999, 117 (04) : 838 - 847
12345